108 filings
Page 5 of 6
8-K
ebf81vy12lj5i 9y
6 Apr 21
Entry into a Material Definitive Agreement
4:30pm
10-K
ttk35ren2 9zp28zi
31 Mar 21
Annual report
4:30pm
8-K
7b57z aro5zv3
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
EFFECT
2ilqxbo6bp9cxgj
5 Feb 21
Notice of effectiveness
12:15am
CORRESP
of8o07j
3 Feb 21
Correspondence with SEC
12:00am
UPLOAD
hv20ar8
3 Feb 21
Letter from SEC
12:00am
S-3
ilo4sjk 6fv
29 Jan 21
Shelf registration
4:48pm
8-K
t5ksih1m5 pn81ev
25 Jan 21
Departure of Directors or Certain Officers
5:11pm
S-8
zmoy c1cel8xj
22 Jan 21
Registration of securities for employees
4:15pm
8-K
tguzlve
19 Jan 21
Regulation FD Disclosure
9:10am
8-K/A
f20g97yj
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
n8l7jn 759gmwet6hfkp
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
3y8tt3
10 Dec 20
Completion of Acquisition or Disposition of Assets
5:28pm
8-K
dq25h 0h7r4tcko
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-A12B
x0avh9
1 Dec 20
Registration of securities on exchange
9:25am
SEC STAFF
s7k4yjkkubdi e7
3 Nov 20
SEC staff action: Order
12:00am
424B3
u0js7iu
2 Nov 20
Prospectus supplement
12:00am
EFFECT
ymvq1kjfso
30 Oct 20
Notice of effectiveness
12:16am
CORRESP
653y 8qqi3p504ua
27 Oct 20
Correspondence with SEC
12:00am